- Conditions
- Venous Malformation, Lymphatic Malformation, Venolymphatic Malformation
- Interventions
- VT30
- Drug
- Lead sponsor
- Venthera, Inc., a BridgeBio company
- Industry
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 15
- States / cities
- Phoenix, Arizona • Little Rock, Arkansas • Palo Alto, California + 12 more
Source: ClinicalTrials.gov public record
Updated Aug 3, 2022 · Synced May 21, 2026, 10:00 PM EDT